Skip to main content

and
  1. No Access

    Article

    Enzyme replacement therapy for Morquio A: an active recombinant N-acetylgalactosamine-6-sulfate sulfatase produced in Escherichia coli BL21

    Mucopolysaccharidosis IVA (MPS IVA) is an autosomal recessive disorder caused by N-acetylgalactosamine-6-sulfate sulfatase (GALNS) deficiency. Currently no effective therapies exist for MPS IVA. In this work, pro...

    Alexander Rodríguez, Ángela J. Espejo in Journal of Industrial Microbiology & Biote… (2010)